Royal London Asset Management Ltd. Decreases Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Royal London Asset Management Ltd. reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.3% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 348,421 shares of the medical equipment provider's stock after selling 11,818 shares during the quarter. Royal London Asset Management Ltd. owned about 0.10% of Intuitive Surgical worth $171,169,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of ISRG. Ridgewood Investments LLC acquired a new stake in Intuitive Surgical during the second quarter worth about $26,000. Godsey & Gibb Inc. raised its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. LGT Financial Advisors LLC raised its position in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock valued at $30,000 after acquiring an additional 54 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. Finally, Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the 3rd quarter worth $38,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Down 0.5 %

ISRG traded down $2.81 during midday trading on Thursday, hitting $547.14. The company's stock had a trading volume of 343,995 shares, compared to its average volume of 1,444,784. The firm has a market cap of $194.88 billion, a P/E ratio of 88.18, a PEG ratio of 5.33 and a beta of 1.38. Intuitive Surgical, Inc. has a 52-week low of $307.72 and a 52-week high of $552.08. The firm has a 50-day moving average price of $513.56 and a two-hundred day moving average price of $472.07.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insiders Place Their Bets

In other news, General Counsel Gary Loeb sold 300 shares of Intuitive Surgical stock in a transaction on Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the sale, the general counsel now directly owns 1,595 shares of the company's stock, valued at approximately $757,625. This trade represents a 15.83 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 51,023 shares of company stock valued at $26,384,247 in the last three months. Insiders own 0.90% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ISRG. Truist Financial raised their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a "buy" rating in a research note on Monday, October 14th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an "outperform" rating in a report on Friday, October 18th. Piper Sandler reissued an "overweight" rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and boosted their target price for the stock from $522.00 to $650.00 in a research report on Monday. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $541.33.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.